NEUNEUREN PHARMACEUTICALS LIMITED

Priority Review Voucher program reauthorized by US Congress

Date and time
Announcement type
Company Administration

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV